However, it is noteworthy that although we found divergences in amyloid processing between CNS syndromes and GBS in COVID‐19, these generally did not reach statistical significance.
1
—
—
However, it is noteworthy that although we found divergences in amyloid processing between CNS syndromes and GBS in COVID‐19, these generally did not reach statistical significance.